- Conditions
- Thrombotic Thrombocytopenic Purpura
- Interventions
- Octaplas, Standard Plasma
- Biological · Drug
- Lead sponsor
- Octapharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 2
- States / cities
- Manhasset, New York • Rochester, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Adverse Effects in the Therapeutic Use of Plasma Substitutes
- Interventions
- Octaplas™
- Biological
- Lead sponsor
- Octapharma
- Industry
- Eligibility
- 2 Years to 20 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 8
- States / cities
- Birmingham, Alabama • Atlanta, Georgia • New Orleans, Louisiana + 5 more
- Conditions
- Coagulopathy, Endstage Liver Disease
- Interventions
- Octaplas™, Plasma
- Biological
- Lead sponsor
- Octapharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 4
- States / cities
- Loma Linda, California • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania + 1 more